Mireille Sanders
Chief Operating Officer bij PHARMING GROUP N.V.
Vermogen: 879 337 $ op 31-03-2024
Actieve functies van Mireille Sanders
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PHARMING GROUP N.V. | Chief Operating Officer | 15-12-2020 | - |
| Corporate Officer/Principal | 01-05-2019 | 15-12-2020 |
Loopbaan van Mireille Sanders
Eerdere bekende functies van Mireille Sanders
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01-01-2016 | 01-01-2019 |
Opleiding van Mireille Sanders
| Technische Universiteit Eindhoven | Graduate Degree |
Statistieken
Internationaal
| Nederland | 3 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARMING GROUP N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Beurs
- Insiders
- Mireille Sanders
- Ervaring
